4D Molecular Therapeutics Inc
1 day chart
4D Molecular Therapeutics, Inc. is a clinical-stage biotherapeutics company. The Company is developing a diverse pipeline of product candidates for both large market and rare diseases, including patient populations that other genetic medicines are unable to address. The Company's initial product candidates are focused on therapeutic areas, such as ophthalmology, pulmonology, and cardiology. The Company's five product candidates include 4D-150, 4D-710, 4D-125, 4D-110, and 4D-310. 4D-150 is used for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). 4D-710 is used for the treatment of cystic fibrosis lung disease (both in modulator ineligible and eligible populations). 4D-310 is used for the treatment of Fabry disease cardiomyopathy. 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP). 4D-110 is used for the treatment of choroideremia.
Buy US stocks in Australia starting with FDMT. Open an account and start investing today!
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in FDMT
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.